Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects
about
Pharmacokinetics and safety of recently approved drugs used to treat methicillin-resistant Staphylococcus aureus infections in infants, children and adults.Ceftaroline fosamil: a brief clinical review.Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model.Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal MicrobiotaPharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjectsPipeline of Known Chemical Classes of Antibiotics.Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.Cephalosporins currently in early clinical trials for the treatment of bacterial infections.Pharmacokinetic and pharmacodynamic evaluation of ceftaroline fosamil.Distinctive Binding of Avibactam to Penicillin-Binding Proteins of Gram-Negative and Gram-Positive Bacteria.A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline.The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?β-Lactamase inhibition by avibactam in Mycobacterium abscessus.Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam.Single- and Repeated-Dose Pharmacokinetics of Ceftaroline in Plasma and Soft Tissues of Healthy Volunteers for Two Different Dosing Regimens of Ceftaroline FosamilCeftaroline efficacy against high-MIC clinical Staphylococcus aureus isolates in an in vitro hollow-fibre infection model.Randomized, placebo-controlled study to assess the impact on QT/QTc interval of supratherapeutic doses of ceftazidime-avibactam or ceftaroline fosamil-avibactam.
P2860
Q33657212-D0860282-8EB1-442B-A590-707166E1FC89Q33939080-C3885B08-EE44-4394-9E58-C73CDA9384D9Q34596373-7EF77DAB-73F7-472D-A4C1-FE5C52EE9448Q35634838-4932AAC7-8520-497D-8252-49B6E4C80F54Q35746176-D8B14392-4C51-4A69-BD02-CB75D76537DBQ36683409-E3E65E68-5A27-4255-8E3C-7668404FA877Q38185097-E48D1D66-07E6-4E03-8A10-40276863BE63Q38222497-999B0B57-8C2A-48B1-AD26-49F97A06EE15Q38262950-2786CCD8-F24A-4662-8950-1939612036B8Q38367722-40327A58-640C-4D4E-9559-7606733E3B8EQ38458802-CF63D91C-6418-4D07-8D54-BF90A71FB1DAQ38892589-FEC31912-ADBA-4446-A220-D512CB39D609Q38927000-55227F7E-31B8-477E-A484-7D82EFEAFBD2Q39001350-DB121481-EF35-4D5A-984C-9A53C103B900Q39226965-66A29352-3FC1-4388-A651-C9E1F6B4F7FCQ47677671-2619BC97-465A-4989-B7D0-14199DB5AF3FQ54709896-A61D0825-2B13-4A88-A756-B2F184342338
P2860
Single- and multiple-dose study to determine the safety, tolerability, and pharmacokinetics of ceftaroline fosamil in combination with avibactam in healthy subjects
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Single- and multiple-dose stud ...... avibactam in healthy subjects
@ast
Single- and multiple-dose stud ...... avibactam in healthy subjects
@en
type
label
Single- and multiple-dose stud ...... avibactam in healthy subjects
@ast
Single- and multiple-dose stud ...... avibactam in healthy subjects
@en
prefLabel
Single- and multiple-dose stud ...... avibactam in healthy subjects
@ast
Single- and multiple-dose stud ...... avibactam in healthy subjects
@en
P2093
P2860
P356
P1476
Single- and multiple-dose stud ...... avibactam in healthy subjects
@en
P2093
Douglas Rank
Sheng Fang Su
Todd A Riccobene
P2860
P304
P356
10.1128/AAC.02134-12
P407
P577
2013-01-07T00:00:00Z